METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease—protocol for a multicentre, non-randomised, single-arm, prospective study
<strong>Introduction </strong>Crohn’s disease (CD) is characterised by discontinuous, relapsing enteric inflammation. Instituting advanced therapies at an early stage to suppress inflammation aims to prevent future complications such as stricturing or penetrating disease, and subsequent...
Main Authors: | Kumar, S, Plumb, A, Mallett, S, Bhatnagar, G, Bloom, S, Clarke, CS, Hamlin, J, Hart, AL, Jacobs, I, Travis, S, Vega, R, Halligan, S, Taylor, SA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2022
|
Similar Items
-
Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial
by: Taylor, SA, et al.
Published: (2018) -
Diagnostic performance of magnetic resonance enterography disease activity indices compared with a histological reference standard for adult terminal ileal Crohn’s disease: experience from the METRIC trial
by: Kumar, S, et al.
Published: (2022) -
METRIC (MREnterography or ulTRasound in Crohn’s disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and over
by: Taylor, S, et al.
Published: (2014) -
Crohn’s disease or Crohn’s diseases?
by: Arnott, IDR, et al.
Published: (2003) -
Medical management of Crohn's disease.
by: Cummings, JR, et al.
Published: (2008)